| Code | Name | Deposits | Targets | Ligand Type |
|---|---|---|---|---|
| P33 | 3,6,9,12,15,18-hexaoxaicosane-1,20-diol | 3 | 3 | crystallization |
| CSO | S-HYDROXYCYSTEINE | 3 | 3 | modified residue |
| Q21 | unknown | 3 | 3 | biological |
| DC | unknown | 3 | 2 | biological |
| TOY | tobramycin | 3 | 3 | biological |
| NAJ | nicotinamide-adenine-dinucleotide (acidic form) | 2 | 1 | biological |
| CS | 2 | 1 | crystallization | |
| CS | 2 | 1 | biological | |
| NAP | 2 | 2 | other | |
| CPS | 3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfona te | 2 | 2 | crystallization |
| CP | carbamoyl phosphate | 2 | 1 | biological |
| ADN | adenosine | 2 | 2 | biological |
| 5GP | guanosine-5'-monophosphate | 2 | 2 | biological |
| MX2 | unknown | 2 | 1 | biological |
| MTX | 2 | 2 | biological | |
| MYR | 2 | 1 | biological | |
| MOH | methanol | 2 | 1 | crystallization |
| 176 | 2 | 2 | biological | |
| MLT | 2 | 2 | other | |
| CL | chloride | 2 | 2 | modified residue |